Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding

Nature Medicine

Volumn 6, Issue 6, 2000, Pages 707-710

  Bodinier, Marie ^a   Peyrat, Marie Alix ^a   Tournay, Claire ^b   Davodeau, François ^a   Romagne, François ^b   Bonneville, Marc ^a   Lang, François ^a  

^a INSERM   (France)

^b Immunotech   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN BINDING; CELL SELECTION; CELL SEPARATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD8; HLA-A2 ANTIGEN; HUMANS; IMMUNOMAGNETIC SEPARATION; PEPTIDES; STAINING AND LABELING; T-LYMPHOCYTES;

EID: 0034047716     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/76292     Document Type: Short Survey

References (14)

1. Altman, J.D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
2. Busch, D.H., Pilip, I.M., Vijh, S. & Pamer, E.G. Coordinate regulation of complex T-cell populations responding to bacterial infection. Immunity 8, 353-362 (1998).
3. Bousso, P. et al. Individual variations in the murine T-cell response to a specific peptide reflect variability in naive repertoires. Immunity 9, 169-178 (1998).
4. Lee, P.P. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nature Med. 5, 677-685 (1999).
5. Salter, R.D. et al. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature 338, 345-347 (1989).
6. Salter, R.D. et al. A binding site for the T-cell coreceptor CD8 on the α3 domain of HLA-A2. Nature 345, 41-46 (1990).
7. Scotet, E. et al. T-cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J. Exp. Med. 184, 1791-1800 (1996).
8. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187, 1395-1402 (1998).
9. Ogg, G.S. et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106 (1998).
10. + T cells usable in immunotherapy. Nature Biotechnol. 16, 281-285 (1998).
11. Garboczi, D.N., Hung, D.T. & Wiley, D.C. HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89, 3429-3433 (1992).
12. Coulie, P.G. et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35-42 (1994).
13. Gervois, N., Guilloux, Y., Diez, E. & Jotereau, F. Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med. 183, 2403-2407 (1996).
14. Couedel, C. et al. Selection and long-term persistence of reactive CTL clones during an EBV chronic response are determined by avidity, CD8 variable contribution compensating for differences in TCR affinities. J. Immunol. 162, 6351-6358 (1999).